Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Front Med (Lausanne) ; 11: 1382672, 2024.
Article in English | MEDLINE | ID: mdl-38572155

ABSTRACT

Background: Non-gestational choriocarcinoma, also known as primary choriocarcinoma, is extremely rare in men, manifesting with specific signs such as breast feminization, testicular atrophy, and loss of libido. The presentation typically includes elevated serum ß-hCG levels, widespread metastatic disease, and a rapid progression of the condition. Case report: We present a rare case of a 41-year-old man diagnosed with choriocarcinoma, exhibiting a unique combination of multiple metastases, including lung, brain, bone, and retroperitoneal lymph node metastases, as confirmed by 18F-FDG PET/CT imaging. The patient was treated with aggressive chemotherapy and pembrolizumab, and the prognosis remained poor. The patient's overall survival was a mere 5 months following diagnosis. Conclusion: Non-gestational choriocarcinoma represents a rare entity in clinical practice and should be considered in young men presenting with gynaecomastia and elevated ß-hCG levels alongside normal gonads. Thus, we advocate for a more comprehensive inquiry into medical history and a systematic examination. The 18F-FDG PET/CT examination not only visually delineates the lesion's location and extent but also serves as a cornerstone for clinical tumor staging, providing valuable support for treatment monitoring and subsequent follow-up.

2.
Cureus ; 15(7): e41823, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37575827

ABSTRACT

Choriocarcinoma is a highly aggressive, malignant tumor that arises from trophoblastic cells. Although choriocarcinomas usually arise in the genital organs, they can also originate in extragenital organs, but gastrointestinal tract lesions are rare. Gastrointestinal choriocarcinoma can be primary or metastatic. Most primary gastrointestinal choriocarcinomas are associated with adenocarcinomas. We report a case of jejunal choriocarcinoma presenting with acute abdominal pain and intestinal bleeding. The patient had a very high serum beta-human chorionic gonadotropin (ß-HCG) level with an isolated jejunal lesion on contrast-enhanced computed tomography of the abdomen and pelvis. The patient underwent emergency surgical resection of the jejunal lesion with good recovery. The histopathological analysis of the resected specimen confirmed the diagnosis of choriocarcinoma. However, the patient suffered from life-threatening rebleeding one month after surgery and succumbed to her illness.

3.
Cureus ; 15(7): e42374, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37492037

ABSTRACT

Bilateral synchronous testicular tumors are a relatively uncommon occurrence, especially when they involve germ cell tumors of different histology. In this context, we present a compelling case report of a male patient who was diagnosed with bilateral synchronous germ cell testicular tumors, with one being a seminoma and the other a non-seminomatous germ cell tumor (NSGCT). The coexistence of two distinct histological types, seminoma and NSGCT, necessitates a comprehensive diagnostic approach to accurately identify and characterize each tumor. This underscores the importance of clinical history, physical examination, imaging techniques, and histopathological analysis to establish an appropriate diagnosis. Careful consideration must be given to factors such as tumor stage, histological subtype, and individual patient characteristics to determine the most suitable treatment strategy. Treatment options may encompass a combination of surgery, chemotherapy, and radiation therapy, tailored to each tumor's specific characteristics and the patient's overall health. By highlighting this unique case, we aim to underscore the significance of meticulous evaluation and accurate diagnosis when confronted with bilateral synchronous testicular tumors of different histology.

4.
Cancer Res Treat ; 53(3): 874-880, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33285049

ABSTRACT

PURPOSE: The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020. MATERIALS AND METHODS: We reviewed the clinical records of 14 male patients with PCC retrospectively to assess their demographic, histological, and clinical characteristics at the time of diagnosis as well as identify the treatment outcomes. RESULTS: The median age of the patients was 33 years. The primary tumor site was the testicles in seven cases (50%), the mediastinum in six cases (43%), and the brain in one case (7%). The most common metastatic site was the lungs (79%), followed by the brain (43%). All patients with PCC received cytotoxic chemotherapy. Twelve patients had records of their response to cytotoxic chemotherapy; of these 12 patients, eight (8/12, 67%) achieved an objective response, and four (4/12, 33%) achieved stable disease response as the best response during chemotherapy. CONCLUSION: It is known that most male PCC patients eventually develop resistance to cytotoxic chemotherapy and die. Factors such as poor response to chemotherapy, high disease burden, brain metastasis, and hemoptysis at the time of diagnosis are associated with shorter survival time in male PCC patients. Programmed death-1/programmed death-ligand 1 blockade therapy can be a salvage treatment for chemotherapy-resistant male PCC patients.


Subject(s)
Brain Neoplasms/diagnosis , Choriocarcinoma, Non-gestational/diagnosis , Lung Neoplasms/diagnosis , Mediastinal Neoplasms/diagnosis , Testicular Neoplasms/diagnosis , Adult , B7-H1 Antigen/antagonists & inhibitors , Biomarkers, Tumor/analysis , Brain Neoplasms/drug therapy , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Choriocarcinoma, Non-gestational/drug therapy , Choriocarcinoma, Non-gestational/mortality , Choriocarcinoma, Non-gestational/secondary , Drug Resistance, Neoplasm , Humans , Immune Checkpoint Inhibitors/pharmacology , Immune Checkpoint Inhibitors/therapeutic use , Lung Neoplasms/drug therapy , Lung Neoplasms/mortality , Lung Neoplasms/secondary , Male , Mediastinal Neoplasms/drug therapy , Mediastinal Neoplasms/mortality , Mediastinal Neoplasms/pathology , Middle Aged , Republic of Korea/epidemiology , Retrospective Studies , Salvage Therapy/methods , Testicular Neoplasms/drug therapy , Testicular Neoplasms/mortality , Testicular Neoplasms/pathology , Treatment Outcome , Young Adult
6.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-669189

ABSTRACT

Primary mediastinal choriocarcinoma in male is not a very common disease,with nonspecific clinical manifestations.Gynecomastia and testicular atrophy are present in some cases.The levels of serum human chorionic gonadotropin are often significantly increased.Giant lump in the mediastinum and bilateral lungs multiple metastases can be seen on the computed tomography for lung.The diagnosis for it depends on pathological biopsy.Current treatment method is a comprehensive,consisting of chemotherapy,radiotherapy and surgery.This paper reported a case of primary mediastinal choriocarcinoma in male,who were diagnosed and treated in the Second Xiangya Hospital of Central South University.He was admitted for cough and hemoptysis,and finally diagnosed by biopsy.The prognosis is very poor.Therefore,it is important to take physical examination regularly because it can be detected and diagnosed early.

7.
J Nat Sci Biol Med ; 4(2): 497-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-24082764

ABSTRACT

Choriocarcinoma is a highly malignant tumor of the trophoblastic origin. Most cases are present within 1 year of antecedent pregnancy. We present an extremely rare case of choriocarcinoma of the anterior abdominal muscle in a 41-year-old female who presented as mass in anterior abdominal wall 4 months after undergoing a total abdominal hysterectomy with bilateral salpingo oophorectomy for a diagnosis of fibroid uterus. Laparotomy done for the mass revealed it to be an extraperitoneal mass within the rectus muscle that on histopathological examination was confirmed to be primary choriocarcinoma. Computed tomography scan revealed pulmonary metastases and patient was given combination chemotherapy to which she responded well.

8.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-158961

ABSTRACT

A primary choriocarcinoma of the lung is extremely rare, and difficult to distinguish from a metastatic choriocarcinoma considering that the lung is also one of the most frequent sites of metastasis. We report a 28-year-old woman patient who was initially misdiagnosed with an ectopic pregnancy and was operated on under the impression of an unidentified malignancy of the lung, which was finally proven to be a choriocarcinoma of the lung. A pelvic examination by a gynecologist, pelvic magnetic resonance imaging and whole body fluorodeoxyglucose positron emission tomography-computed tomography was performed in order to rule out a metastatic choriocarcinoma of the lung. After a curative operation, her serum beta-human chorionic gonadotropin (HCG) level, which was highly elevated in the initial evaluation, had decreased dramatically to the normal range. She is currently being followed up regularly without any evidence of recurrence or elevation of her beta-HCG level.


Subject(s)
Adult , Female , Humans , Pregnancy , Choriocarcinoma , Chorionic Gonadotropin , Electrons , Gynecological Examination , Lung , Magnetic Resonance Imaging , Neoplasm Metastasis , Pregnancy, Ectopic , Recurrence , Reference Values
9.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-43804

ABSTRACT

Primary choriocarcinoma of fallopian tube is a extremely rare. At the time of initial presentation, symptoms are usually similar to those of traditional tubal pregnancies. The diagnosis is usually made on histological examination of a surgically resected specimen. Chemotherapy is required in most patients following initial operation including unilateral adnexectomy or salpingectomy. Primary choriocarcinoma of fallopian tube appears to have the same favorable prognosis as does uterine choriocarcinoma. We experienced one case of primary choriocarcinoma of fallopian tube, and report this with brief review of the literatures.


Subject(s)
Female , Humans , Pregnancy , Choriocarcinoma , Diagnosis , Drug Therapy , Fallopian Tubes , Pregnancy, Tubal , Prognosis , Salpingectomy
10.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-14829

ABSTRACT

Primary choriocarcinoma of the fallopian tube has been known for 4% of choriocarcinoma also 1.7% of gestational trophoblastic disease. Its symptom and sign in presentation are similar to the ectopic pregnancy or adnexal mass, thus it is confirmed through histopathological descriptions after explolaparotomy or laparoscopy. Mostly it is common in younger women who are reproductive, we have done conservative surgery followed by chemotherapy. After that, the prognosis was good. We have experienced a case of primary choriocarcinoma of the fallopian tube and reported with a brief review.


Subject(s)
Female , Humans , Pregnancy , Choriocarcinoma , Drug Therapy , Fallopian Tubes , Gestational Trophoblastic Disease , Laparoscopy , Pregnancy, Ectopic , Prognosis
11.
Article in Korean | WPRIM (Western Pacific) | ID: wpr-217363

ABSTRACT

Choriocarcinoma is a relatively rare malignancy of which characteristic is rapid metastasis to the other organs. It is related to the previous gestation or originated from the teratoma. Choriocarcinoma is mostly originated from the intrauterine chorionic villi, but it is rarely originated from the utreine cervix, fallopian tube, ovary, vagina and pelvic cavity. Primary choriocarcinoma of the fallopian tube is exceedingly rare and it is originated from ectopic tubal pregnancy, tubal migration from the intrauterine pregnancy or intratubal teratoma. 9 Symptoms and signs of the choriocarcinoma originated from the ectopic pregnancy are abdominal pain, vaginal bleeding, palpable adnexal mass, positive pregnancy test and amenorrhea. Thus it is difficult to distinguish choriocarcinoma from ectopic pregnancy on the basis of symptoms before the microscopic diagnosis presented.20 Effective treatment of choriocarcinoma is chemotherapy. Additional operation is possible. B-HCG is a useful measure for the follow up. We experienced a 36-year-old multigravida Korean woman who was diagnosed as the rupture of ectopic pregnancy after left salpingectomy in our hospital and then confirmed primary choriocarcinoma of the fallopian tube without metastasis on microscopic finding. Postoperative chemotherapy was performed with methotrexate. The follow up of disease is still on going at two month intervals and she has remained healthy, We report this case with review of literatures.


Subject(s)
Adult , Female , Humans , Pregnancy , Abdominal Pain , Amenorrhea , Cervix Uteri , Choriocarcinoma , Chorionic Villi , Diagnosis , Drug Therapy , Fallopian Tubes , Follow-Up Studies , Methotrexate , Neoplasm Metastasis , Ovary , Pregnancy Tests , Pregnancy, Ectopic , Pregnancy, Tubal , Rupture , Salpingectomy , Teratoma , Uterine Hemorrhage , Vagina
SELECTION OF CITATIONS
SEARCH DETAIL
...